My Cart

Nkp46

Nkp46 Overview

English NameNatural cytotoxicity triggering receptor 1Approved Drugs0
Drugs in Clinical Trials3Target SynonymNK cell-activating receptor,NK-p46,Lymphocyte antigen 94 homolog,NKp46,hNKp46,Lymphocyte Antigen 94 Homolog (Activating NK-Receptor; NK-P46),Natural killer cell p46-related protein,LY94,Lymphocyte Antigen 94 (Mouse) Homolog (Activating NK-Receptor; NK-P46),CD335 Antigen,CD335
Highest Development StagePhase 2 Clinical
English NameNatural cytotoxicity triggering receptor 1
Target SynonymNK cell-activating receptor,NK-p46,Lymphocyte antigen 94 homolog,NKp46,hNKp46,Lymphocyte Antigen 94 Homolog (Activating NK-Receptor; NK-P46),Natural killer cell p46-related protein,LY94,Lymphocyte Antigen 94 (Mouse) Homolog (Activating NK-Receptor; NK-P46),CD335 Antigen,CD335
Approved Drugs0
Drugs in Clinical Trials3
Highest Development StagePhase 2 Clinical

Nkp46 Background

Natural cytotoxicity triggering receptor 1 (NCR1) is also known as Natural killer cell p46-related protein (NK-p46), Lymphocyte antigen 94 homolog (LY94), CD antigen CD335, which belongs to the natural cytotoxicity receptor (NCR) family. NCR1 contains two Ig-like (immunoglobulin-like) domains. NCR1 interacts with CD247 and FCER1G. NCR1 / CD335 may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis.

Nkp46 Synonyms

Nkp46

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
NY-303NY-303Phase 2 ClinicalNAYA Biosciences IncCarcinoma, Hepatocellular; Solid tumours
Details
IPH-6501IPH-6501; IPH-65Phase 2 ClinicalInnate Pharma SALymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms
Details
SAR-443579SAR-443579; SAR443579; SAR'579; IPH6101; IPH-6101Phase 1 ClinicalSanofiBlastic Plasmacytoid Dendritic Cell Neoplasm; Hematologic Diseases; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Details
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland